Primary Site >> Stomach Cancer
Gene >> CCL22
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. PMID: 18224687 |
Ref: Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma. PMID: 19298002 |
Ref: Morphometric analysis of the balance between CXCR3+ T cells and FOXP3+ regulatory T cells in lymphocyte-rich and conventional gastric cancers. PMID: 20422211 |
Ref: Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker. PMID: 25154912 Ref: The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots. PMID: 25245466 |
Ref: Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma. PMID: 26673957 |
Ref: C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy. PMID: 28501127 |
Ref: C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer. PMID: 29872564 |